Your browser doesn't support javascript.
loading
Endothelial TIE1 Restricts Angiogenic Sprouting to Coordinate Vein Assembly in Synergy With Its Homologue TIE2.
Cao, Xudong; Li, Taotao; Xu, Beibei; Ding, Kai; Li, Weimin; Shen, Bin; Chu, Man; Zhu, Dengwen; Rui, Li; Shang, Zhi; Li, Xiao; Wang, Yinyin; Zheng, Shuyu; Alitalo, Kari; Liu, Ganqiang; Tang, Jing; Kubota, Yoshiaki; He, Yulong.
Afiliação
  • Cao X; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Li T; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Xu B; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Ding K; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Li W; Neurobiology Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, China (W.L., G.L.).
  • Shen B; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Chu M; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Zhu D; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Rui L; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Shang Z; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Li X; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
  • Wang Y; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Finland (Y.W., S.Z., J.T.).
  • Zheng S; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Finland (Y.W., S.Z., J.T.).
  • Alitalo K; Wihuri Research Institute and Translational Cancer Medicine Research Program, Biomedicum Helsinki, Finland (K.A.).
  • Liu G; Neurobiology Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Shenzhen, Guangdong, China (W.L., G.L.).
  • Tang J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Finland (Y.W., S.Z., J.T.).
  • Kubota Y; Department of Anatomy, Keio University School of Medicine, Tokyo, Japan (Y.K.).
  • He Y; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Diseases, State Key Laboratory of Radiation Medicine and Protection, Cam-Su Genomic Resources Center, Suzhou Medical College of Soochow University, Suzhou, Jiangsu, China (X
Arterioscler Thromb Vasc Biol ; 43(8): e323-e338, 2023 08.
Article em En | MEDLINE | ID: mdl-37317851
ABSTRACT

BACKGROUND:

Vascular growth followed by vessel specification is crucial for the establishment of a hierarchical blood vascular network. We have shown that TIE2 is required for vein development while little is known about its homologue TIE1 (tyrosine kinase with immunoglobulin-like and EGF [epithelial growth factor]-like domains 1) in this process.

METHODS:

We analyzed functions of TIE1 as well as its synergy with TIE2 in the regulation of vein formation by employing genetic mouse models targeting Tie1, Tek, and Nr2f2, together with in vitro cultured endothelial cells to decipher the underlying mechanism.

RESULTS:

Cardinal vein growth appeared normal in TIE1-deficient mice, whereas TIE2 deficiency altered the identity of cardinal vein endothelial cells with the aberrant expression of DLL4 (delta-like canonical Notch ligand 4). Interestingly, the growth of cutaneous veins, which was initiated at approximately embryonic day 13.5, was retarded in mice lack of TIE1. TIE1 deficiency disrupted the venous integrity, displaying increased sprouting angiogenesis and vascular bleeding. Abnormal venous sprouts with defective arteriovenous alignment were also observed in the mesenteries of Tie1-deleted mice. Mechanistically, TIE1 deficiency resulted in the decreased expression of venous regulators including TIE2 and COUP-TFII (chicken ovalbumin upstream promoter transcription factor, encoded by Nr2f2, nuclear receptor subfamily 2 group F member 2) while angiogenic regulators were upregulated. The alteration of TIE2 level by TIE1 insufficiency was further confirmed by the siRNA-mediated knockdown of Tie1 in cultured endothelial cells. Interestingly, TIE2 insufficiency also reduced the expression of TIE1. Combining the endothelial deletion of Tie1 with 1 null allele of Tek resulted in a progressive increase of vein-associated angiogenesis leading to the formation of vascular tufts in retinas, whereas the loss of Tie1 alone produced a relatively mild venous defect. Furthermore, the induced deletion of endothelial Nr2f2 decreased both TIE1 and TIE2.

CONCLUSIONS:

Findings from this study imply that TIE1 and TIE2, together with COUP-TFII, act in a synergistic manner to restrict sprouting angiogenesis during the development of venous system.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de TIE-1 / Receptor TIE-2 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Arterioscler Thromb Vasc Biol Assunto da revista: ANGIOLOGIA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor de TIE-1 / Receptor TIE-2 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Arterioscler Thromb Vasc Biol Assunto da revista: ANGIOLOGIA Ano de publicação: 2023 Tipo de documento: Article